Rchr
J-GLOBAL ID：202001021219275793
Update date: Nov. 11, 2024
Yamamichi Gaku
ヤマミチ ガク | Yamamichi Gaku
Affiliation and department：
Research theme for competitive and other funds (2)：
- 2021 - 2024 大阪臨床研究ネットワーク基盤を利用した新規骨転移血液バイオマーカーの多施設研究
- 2020 - 2022 Elucidation of the mechanism of expression of GDPP, a novel blood biomarker of bone metastases
Papers (86)：
-
Akinaru Yamamoto, Atsunari Kawashima, Shinsuke Sakai, Masashi Mita, Nesrine Sassi, Shunsuke Inoguchi, Yuki Horibe, Akihiro Yoshimura, Masaru Tani, Liu Yutong, et al. Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma. Biochemical and biophysical research communications. 2024. 733. 150701-150701
-
Akihiro Yoshimura, Taigo Kato, Yasutomo Nakai, Masao Tsujihata, Shingo Toyoda, Mototaka Sato, Kyosuke Matsuzaki, Wataru Nakata, Tetsuya Takao, Syunsuke Inoguchi, et al. Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan. International journal of clinical oncology. 2024
-
山道 岳, 加藤 大悟, 荒川 憲昭, 氏家 剛, 本山 雄一, 王谷 英達, 明庭 昇平, 石津谷 祐, 山本 致之, 波多野 浩士, et al. GDPPはvicious cycleを亢進させて骨転移を有する去勢抵抗性前立腺癌における血中骨転移バイオマーカーとなる. 泌尿器外科. 2024. 37. 8. 892-893
-
植村 俊彦, 河嶋 厚成, 神宮司 健太郎, 元岡 大祐, ネスリン・サッシ, 岡 利樹, 奥田 洋平, 山本 顕生, 山道 岳, 冨山 栄輔, et al. 血中細胞外小胞内の細菌由来DNAは腎癌診断および免疫治療予後予測マーカーとなる. 腎癌研究会会報. 2024. 54. 116-116
-
Masaru Tani, Koji Hatano, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, et al. Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management. Scientific reports. 2024. 14. 1. 13451-13451
ｍore...
MISC (141)：
-
河嶋厚成, 山本顕生, ネスリン サッシ, 木村友則, 三田真史, 神宮司健太郎, 植村俊彦, 山道岳, 冨山栄輔, 石津谷祐, et al. Diagnostic and prognostic markers using bacterial genetic and metabolize information within urogenital cancer patients. 日本癌学会学術総会抄録集(Web). 2023. 82nd
-
SASSI Nesrine, 河嶋厚成, 山本顕生, 木村友則, 三田真史, 植村俊彦, 山道岳, 冨山栄輔, 石津谷祐, 山本致之, et al. Development of blood based diagnostic biomarker of urothelial carcinoma using a chiral amino acid: D-Alanine. 日本癌学会学術総会抄録集(Web). 2023. 82nd
-
河嶋厚成, 山本顕生, NESRINE Sassi, 木村友則, 三田真史, 植村俊彦, 山道岳, 冨山栄輔, 石津谷祐, 山本致之, et al. Development of blood based diagnostic markers of urothelial carcinoma using chiral amino acids. 日本泌尿器科学会総会(Web). 2023. 110th
-
波多野浩士, 岡利樹, 二村圭祐, 石津谷祐, 奥田洋平, 植村俊彦, 山道岳, 冨山栄輔, 山本致之, 加藤大悟, et al. Systematic mapping of radiosensitivity and gene interactions identifies a novel therapeutic target in prostate cancer. 日本泌尿器科学会総会(Web). 2023. 110th
-
山本致之, 山本致之, 河嶋厚成, 河嶋厚成, 森島敏隆, 奥田洋平, 岡利樹, 植村俊彦, 山道岳, 冨山栄輔, et al. Effect of cycle number of platinum-based chemotherapy for metastatic urothelial cancer. 日本泌尿器科学会総会(Web). 2023. 110th
ｍore...
Lectures and oral presentations (2)：
-
High performance of 5-aminolevulinic acid induced fluorescent urine cytology for detecting urothelial carcinoma
(American Urological Association Annual Meeting 2020 2020)
-
High diagnostic efficacy of 5-aminolevulinic acid induced fluorescence urine cytology for urothelial carcinoma
(European Association of Urology Annual Meeting 2019 2019)
Return to Previous Page
